Emerging targets for novel therapy of asthma.
Emerging targets for novel therapy of asthma.
复制标题
DOI:
10.1016/j.coph.2013.04.002
复制
发表时间:
2013-06
影响因子:
4
通讯作者:
Camoretti-Mercado B
中科院分区:
文献类型:
--
作者:
Gerthoffer WT;Solway J;Camoretti-Mercado B
Significant advances in understanding the cell and molecular biology of inflammation and airway smooth muscle (ASM) contractility have identified several potential novel targets for therapies of asthma. New agents targeting G-protein coupled receptors (GPCR) including bitter taste receptors (TAS2R) agonists and prostaglandin EP4 receptor agonists elicit airway smooth muscle relaxation. The cAMP/PKA pathway continues to be a promising drug target with the emergence of new PDE inhibitors and a novel PKA target protein, HSP20, which mediates smooth muscle relaxation via actin depolymerization. Smooth muscle relaxation can also be elicited by inhibitors of the RhoA/Rho kinase pathway via inhibition of myosin light chain phosphorylation and actin depolymerization. Targeting epigenetic processes that control chromatin remodeling and RNA-induced gene silencing in airway cells also holds great potential for novel asthma therapy. Further investigation may identify agents that inhibit smooth muscle contraction and/or restrain or reverse obstructive remodeling of the airways.
登录
查看更多内容
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
5
作者:
Ito, Satoru;Kume, Hiroaki;Naruse, Keiji
通讯作者:
Naruse, Keiji
DOI:
10.1152/ajplung.00235.2007
发表时间:
2008-01-01
影响因子:
4.9
作者:
Komalavilas, Padmini;Penn, Raymond B.;Brophy, Colleen M.
通讯作者:
Brophy, Colleen M.
影响因子:
3.2
作者:
Benyahia, C.;Gomez, I.;Norel, X.
通讯作者:
Norel, X.
影响因子:
4.8
作者:
Dreiza, CM;Brophy, CM;Panitch, A
通讯作者:
Panitch, A